NASDAQ NMS - GLOBAL MARKET · OKYO
-0.33% · -$0.0050 · Vol 105.6K
Market closed · last close 4:00 PM ET · price as of 18:58:34 ET
OKYO Pharma Ltd

OKYO Pharma Ltd

Biotechnology
$1.53
Card
Relationship Map

Veridion Score

BETAMEDIUM CONF · 5/6 factorsMethodology
OKYO
OKYO Pharma Ltd
Fri Aug 7 · last completed session · Markets closed · resumes Mon 9:30 ET
NEUTRAL

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

55/ 100
Veridion Score
NEUTRAL · MEDIUM confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5/6 factors with data · Fri Aug 7 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is OKYO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading OKYO catalysts
About OKYO Pharma Ltd
Biotechnology
Listed since
2022
Employees
5
Country
GB

OKYO Pharma Ltd is a clinical-stage ophthalmology company focused on developing differentiated therapies for corneal and anterior segment diseases. It is advancing a pipeline designed to improve outcomes for patients suffering from debilitating ocular diseases that impact vision and ocular comfort. The company's main program, urcosimod, is being developed as a potential treatment for neuropathic corneal pain. Additionally, its development pipeline includes an exploratory candidate, OK-201, a non-opioid analgesic drug candidate, as a potential drug to treat acute and chronic ocular pain. The company has only one operating segment: the research and development of biotechnological and pharmaceutical products.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$1.52
Day high
$1.54
Day low
$1.47
Previous close
$1.53
52W high
$3.12
-50.96% from high
52W low
$1.37
9% of range
Market cap
$78.2M
EPS
$-0.2397
Beta
0.96
Shares out
52.5M
Volume
105.6K
0.75× rel vol
Avg volume
140.8K
VWAP
$1.49
Price history computed in-house
1W
-8.93%
1M
-9.47%
3M
-7.27%
1Y
-53.21%
YTD
-26.09%
SMA 50 $1.58 · below
SMA 200 $1.85 · below
52W position 9%

OKYO overview

Veridion Score
55
5 of 6 factors measured
Congress receipts
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around OKYO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading OKYO Form 4 filings
Public disclosures

Congress activity in OKYO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for OKYO in the cached public ledger.

Federal contracts

OKYO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for OKYO in this window.
Lobbying spend

OKYO lobbying filings, year to date.

Registered lobbying filings matched to OKYO Pharma Ltd.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for OKYO in this window.
Loading news for OKYO
Analyst ratings
Sovereign unlock shows live analyst consensus for OKYO.
Options
Sovereign unlock shows live options positioning for OKYO.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.